**Core Concept**
Maple syrup urine disease (MSUD) is a congenital metabolic disorder that results from the deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC). This enzyme is essential for the breakdown of the branched-chain amino acids (BCAAs) leucine, isoleucine, and valine. The accumulation of these amino acids and their toxic byproducts in the body leads to the characteristic clinical and biochemical features of the disease.

**Why the Correct Answer is Right**
Phenylalanine is not a branched-chain amino acid, and its metabolism is not affected in maple syrup urine disease. Instead, phenylalanine is metabolized via the phenylalanine hydroxylase pathway, which is a separate and distinct metabolic pathway. This is why phenylalanine is not excreted in the urine in MSUD. The BCKDC enzyme deficiency specifically impairs the breakdown of leucine, isoleucine, and valine, leading to their accumulation and subsequent excretion in the urine.

**Why Each Wrong Option is Incorrect**
**Option A:** Valine is a branched-chain amino acid that is metabolized by the BCKDC enzyme and is indeed excreted in the urine in MSUD.
**Option B:** Leucine is another branched-chain amino acid that is affected by the BCKDC enzyme deficiency and is excreted in the urine in MSUD.
**Option C:** Isoleucine is the third branched-chain amino acid that is metabolized by the BCKDC enzyme and is excreted in the urine in MSUD.

**Clinical Pearl / High-Yield Fact**
Maple syrup urine disease is a classic example of a metabolic disorder that results from a deficiency of a key enzyme involved in amino acid metabolism. It is essential for medical students to understand the biochemical basis of this disease, as well as the characteristic clinical features and laboratory findings that distinguish it from other metabolic disorders.

**✓ Correct Answer: D. Phenylalanine**